Vapourtec’s R-Series flow chemistry system, equipped with a UV-150 photochemical reactor, has been cited in research by ...

Cardiac problems associated with vascular endothelial growth factor inhibitors occur frequently in patients with cancer.

Gardening can have many cardiovascular health benefits, as it encourages physical activity, reduces stress, and can improve diet.

Results of prespecified analyses, presented at the American College of Cardiology Scientific Session, found that tafamidis ...

BMS could soon face competition in the HCM space as Cytokinetics awaits a marketing application decision from the FDA for ...

Emory University School of Medicine, US, has commenced subject enrolment for BioCardia’s Phase III CardiAMP HF II trial.

An autologous point-of-care cell therapy for adults with ischemic HF with reduced ejection fraction was safe and may be beneficial for select candidates, though a pivotal study did not meet its ...

Fire1 announced positive results from the first-in-human study of its novel, implantable heart failure (HF) management system ...

Bristol Myers Squibb announced that mavacamten did not achieve statistical significance in meeting the dual primary endpoints ...

PRINCETON, NJ, USA I April 14, 2025 I Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the ...